operating activities -
Depreciation 2,598 1,457
Amortization of intangible assets 188 143
Deferred income taxes 11,032 9,417
Excess tax benefits from share-based
payments (5,377) (4,905)
Share-based compensation expense 10,443 9,165
Amortization of marketable securities
premiums 716 732
Changes in operating assets and
liabilities:
Member fees receivable (35,642) (35,185)
Prepaid expenses and other current
assets (654) 142
Deferred incentive compensation and
other charges (8,970) (3,375)
Deferred revenues 35,289 26,901
Accounts payable and accrued liabilities 5,890 2,222
Accrued incentive compensation (539) 1,459
Other liabilities 141 876
Net cash flows provided
by operating activities 38,644 29,266
Cash flows from investing activities:
Purchases of property and equipment (6,151) (5,954)
Capitalized software development costs (294) (320)
Cash paid for acquisition, net of cash
acquired - (895)
Redemption of marketable securities 31,605 11,500
Purchases of marketable securities (26,345) (9,500)
Net cash flows used
'/>"/>
SOURCE The Advisory Board Company Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Related medicine news :1.
Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board2.
Dr. Warren Jackman Joins CryoCor Scientific Advisory Board3.
OSHA Seeking Nominations for National Advisory Committee on Occupational Safety and Health4.
National Institutes of Health Appoints Timothy C. Birdsall, ND to CAM Advisory Council5.
Manhattan Research: ePharma Consumer(R) Research and Advisory Service Now Available6.
The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 5, 20087.
Statement from the Consumer Healthcare Products Association on Todays FDA Advisory Committee Meeting on the Efficacy of Phenylephrine in the 10 Mg Oral Dose8.
American Society for Aesthetic Plastic Surgery and American Society of Plastic Surgeons Offer Patient Advisory for those Affected by Fig LipoDissolve Closures9.
FDA Advisory Panel Finds Hologics Adiana(R) Permanent Contraception Approvable10.
Bradmer announces additions to Scientific Advisory Board11.
Antibody Engineering Company f-star Appoints Three Pioneers in Antibody Engineering and Development to its Newly Established Scientific Advisory Board